Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Hestia Capital Partners lowered its stake in the business services company to 14,186,244 shares. Hestia Capital Partners did ...

Dr. Jessica Lichter, Assistant Professor and academic hospitalist at Elmhurst Hospital, part of the New York City Health + ...